CTD Holdings to Host Webinar on its Phase I Clinical Trial for Niemann-Pick Disease Type C
ALACHUA, Fla., Oct. 11, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced a one-hour webinar focused on its ongoing US …